serena williams glp-1 commercial is in a new ad campaign for weight loss medication (GLP-1 from Ro), but this is a complex story with two very different sides. Is this a brave move to normalize the medication or a Serena Williams' GLP-1 Weight Loss

Sci., 2015

Given the fact that SGLT2i and GLP1RA safely reduce HbA1c without increased risk of hypoglycemia or weight gain and have beneficial cardiorenal effects across a broad range of subjects with T2DM, we believe these agents should be considered regardless of the presence of CVD

Larger studies are required to substantiate its role in acute and chronic bacterial and viral infections

The length of time you continue injections also depends on your health goals and whether you are addressing a short-term deficiency or seeking ongoing support

has received consultancy and/or lecture fees from companies with an interest in developing and marketing incretin-based therapies for treatment of type 2 diabetes mellitus (Boehringer Ingelheim, Lilly, Merck/MSD and Novo Nordisk)